Cite
HARVARD Citation
Shah, M. et al. (n.d.). P-297CanStem303C trial: A Phase 3 Study of napabucasin (NAPA) in combination with 5-fluorouracil (5-FU), leucovorin, and irinotecan (FOLFIRI) in adult patients (pts) with previously treated metastatic colorectal cancer (mCRC) - Trial in progress. Annals of oncology. p. . [Online].